PapersPMID:41245414
The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“For inflammatory parameters with fewer than 3 RCTs, magnesium supplementation showed no significant effects on serum IL-6 or tumor necrosis factor-alpha levels.”
- Study
- meta-analysis
- Population
- adults with metabolic syndrome or related insulin-resistant/diabetic conditions, oral magnesium supplementation for at least 2 months versus placebo (meta-analysis, fewer than 3 pooled RCTs for this analyte)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with metabolic syndrome
- Participants
- 444
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 11
magnesium(2+)